Simplified dosing and monitoring of vancomycin for the burn care clinician
- 31 October 1992
- Vol. 18 (5), 355-361
- https://doi.org/10.1016/0305-4179(92)90032-p
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Clearance of vancomycin during continuous arteriovenous hemodiafiltrationCritical Care Medicine, 1990
- Potential Problem with Fluorescence Polarization Immunoassay Cross-Reactivity to Vancomycin Degradation Product CDP-1Therapeutic Drug Monitoring, 1989
- The Influence of Serum Albumin and ??1-Acid Glycoprotein on Vancomycin Protein Binding in Patients with Burn InjuriesJournal of Burn Care & Rehabilitation, 1989
- Mild nephrotoxicity associated with vancomycin useArchives of Internal Medicine, 1989
- Overestimation of Vancomycin Concentrations Utilizing Fluorescence Polarization Immunoassay in Patients on Peritoneal DialysisTherapeutic Drug Monitoring, 1987
- Pharmacokinetics of Vancomycin in AnuriaClinical Infectious Diseases, 1981
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- Increased Glomerular Filtration Rate in Patients with Major Burns and Its Effect on the Pharmacokinetics of TobramycinNew England Journal of Medicine, 1978
- RENAL EXCRETION OF VANCOMYCIN IN KIDNEY DISEASEActa Medica Scandinavica, 1975
- Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular HaemodialysisBMJ, 1970